CSF studies facilitate DNA diagnosis in familial alzheimer's disease due to a presenilin-1 mutation

Susanne T. De Bot, H. P H Kremer, Dennis Dooijes, Marcel M. Verbeek

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

In sporadic Alzheimer's disease (AD), cerebrospinal fluid (CSF) analysis is becoming increasingly relevant to establish an early diagnosis. We present a case of familial AD due to a presenilin-1 mutation in which CSF studies suggested appropriate DNA diagnostics. A 38 year old Dutch man presented with dementia, spastic paraparesis, and frontal executive function impairments, mimicking familial Creutzfeldt Jakob disease and frontotemporal dementia. CSF studies, revealing increased total tau and phosphorylated-tau levels with decreased amyloid-β42, distinguished familial AD from Creutzfeldt Jakob disease and frontotemporal dementia. A causative p.L424R PSEN1 mutation was subsequently identified.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalJournal of Alzheimer's Disease
Volume17
Issue number1
DOIs
Publication statusPublished - 27 Jul 2009
Externally publishedYes

Keywords

  • Amyloid-β
  • Cerebrospinal fluid biomarkers
  • Familial Alzheimer's disease
  • P.L424R
  • Phosphorylated-tau
  • Presenilin-1 mutation
  • Tau protein

Fingerprint

Dive into the research topics of 'CSF studies facilitate DNA diagnosis in familial alzheimer's disease due to a presenilin-1 mutation'. Together they form a unique fingerprint.

Cite this